NCT05970185View on ClinicalTrials.gov

The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Granulocyte Colony-Stimulating Factor
Interventions
DRUG

PEG-rhG-CSF

Subcutaneous injection of polyethylene glycolized recombinant human granulocyte-stimulating factor injection 6mg bid in the experimental group the day after the end of chemotherapy

DRUG

G-CSF

G-CSF 5ug/kg/d from day 5 after the end of chemotherapy until the end of collection

Trial Locations (1)

430071

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER

NCT05970185 - The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization | Biotech Hunter | Biotech Hunter